MYC and B-cell non-Hodgkin lymphoma: For instance, Nakajima et al. [30] reported that HK2 levels were significantly elevated in B-cell lymphoma cells through c-MYC and HIF; HK2 was further overexpressed under a hypoxic microenvironment, triggering cisplatin resistance in B-cell lymphoma [30].